EC
GRTS icon

EcoR1 Capital’s Gritstone bio, Inc. Common Stock GRTS Stock Holding History

EcoR1 Capital’s Portfolio GRTS Stock Details GRTS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-6,012,232
Closed -$77.3M – 98
2021
Q4 		$77.3M Buy
6,012,232
+451,484
+8% +$5M 2.46% 12
2021
Q3 		$60.1M Buy
5,560,748
+2,139,461
+63% +$19.5M 2.09% 14
2021
Q2 		$31.2M Hold
3,421,287
– – 1.17% 18
2021
Q1 		$32.3M Hold
3,421,287
– – 1.43% 20
2020
Q4 		$13.5M Buy
+3,421,287
New +$10.3M 0.72% 24

Other funds holding GRTS

RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
VVM
Versant Venture Management San Francisco, California $163M AUM 240.43% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

EcoR1 Capital's GRTS Position: Q1 2022 in Review

EcoR1 Capital sold out of Gritstone bio, Inc. Common Stock (GRTS) in Q1 2022, closing a stake of 6,012,232 shares — an estimated $77.3M sold.

EcoR1 Capital first reported a position in GRTS in Q4 2020 and held it in 5 quarters. The position peaked at $77.3M in Q4 2021. 117 funds tracked by Wall St. Rank hold GRTS as of Q1 2022.

  • EcoR1 Capital reported no remaining Gritstone bio, Inc. Common Stock position as of Q1 2022 after selling out during the quarter.
  • EcoR1 Capital sold 6,012,232 Gritstone bio, Inc. Common Stock shares in Q1 2022, an estimated $77.3M.
  • EcoR1 Capital first reported a position in Gritstone bio, Inc. Common Stock in Q4 2020 and held it in 5 quarters.
  • EcoR1 Capital's Gritstone bio, Inc. Common Stock position peaked at $77.3M in Q4 2021.
  • 117 funds tracked by Wall St. Rank held Gritstone bio, Inc. Common Stock as of Q1 2022.

Based on EcoR1 Capital's 13F filing for Q1 2022, filed 16 May 2022.